Virtual Incision is a robotic device company that assists medical surgeons. With a mission to create accessible robotic-assisted surgery (RAS), Virtual Incision uses miniRAS tray-to-table designs to enable shorter hospital stays and decrease open surgery conversions. In turn, the small design helps create minimally invasive surgeries for patients. Virtual Incision was founded by Dmitry Oleynikov and Shane Farritor in 2006 and is headquartered in Lincoln, Nebraska.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/19/2023 | Series C | $76.58MM | $xx.xx | $26.02B | Arboretum Ventures, Baird Capital, Bluestem Capital, Cultivate(Md) Capital Funds, Endeavour Vision, Invivium Capital, Prairiegold Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
46,248,867
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Arboretum Ventures, Baird Capital, Bluestem Capital, Cultivate(Md) Capital Funds, Endeavour Vision, Invivium Capital, Prairiegold Venture Partners
|
||||||
01/08/2020 | Series B+ | $20MM | $xx.xx | $10.53B | Bluestem Capital, Genesis Innovation Group, Prairiegold Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
19,720,581
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluestem Capital, Genesis Innovation Group, Prairiegold Venture Partners
|
||||||
12/12/2017 | Series B | $19.88MM | $xx.xx | $7.47B | Prairiegold Venture Partners, Sinopharm Capital | |
Price per Share
$xx.xx
Shares Outstanding
22,662,542
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Prairiegold Venture Partners, Sinopharm Capital
|
||||||
08/06/2015 | Series A-2 | $11.14MM | $xx.xx | $3.73B | Bluestem Capital, Prairiegold Ventures | |
Price per Share
$xx.xx
Shares Outstanding
14,857,689
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluestem Capital, Prairiegold Ventures
|
||||||
11/15/2010 | Series A | $3.25MM | $xx.xx | $1.09B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,006,755
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
01/15/2006 | Series Seed | $634,928.00 | $xx.xx | $317.46MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
39,683
Liquidation Pref Order
6
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|